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Abstract 
Mycobacterium tuberculosis (Mtb) SapM is a secreted virulence factor critical for 
intracellular survival of the pathogen. The role of SapM in phagosome maturation arrest 
in host macrophages suggests its potential as a drug target to assist in the clearance of 
tuberculosis infection. However, the mechanism of action of SapM at the molecular level 
remains unknown. In this study, we provide new insights into the mechanism of catalysis, 
substrate specificity and inhibition of SapM, and we identify the critical residues for 
catalysis and substrate binding. Our findings demonstrate that SapM is an atypical 
monoester alkaline phosphatase, with a serine-based mechanism of catalysis probably 
metal-dependent. Particularly relevant to SapM function and pathogenesis, is its activity 
towards PI(4,5)P2 and PI3P, two phosphoinositides that function at the early stages of 
microbial phagocytosis and phagosome formation. This suggests that SapM may have a 
pleiotropic role with a wider importance on Mtb infection than initially thought. Finally, we 
have identified two inhibitors of SapM, L-ascorbic acid and 2-phospho-L-ascorbic, which 
define two different mechanisms by which the catalytic activity of this phosphatase could 
be regulated. Critically, we demonstrate that 2-phospho-L-ascorbic reduces 
mycobacterial survival in macrophage infections, hence confirming the potential of SapM 
as a therapeutic drug target.  
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Introduction 
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (Mtb), is one 
of the leading causes of death and poverty worldwide. The rise of multi-drug resistant 
(MDR), rifampicin resistant (RR), and extensively drug-resistant (XDR) TB poses 
major challenges in the treatment and eradication of this disease, which claims over 
1.6 million lives every year (WHO TB Report 2017).  
Mtb is an intracellular pathogen that prevents its clearance in the host by blocking 
critical phagosome maturation events inside alveolar macrophages1,2,3. Subversion of 
phosphoinositide (PI) metabolism and dynamics is a key mechanism used by Mtb and 
other bacterial pathogens to arrest phagolysosome fusion thus preventing bacterial 
killing4,5. PIs are essential for the recruitment of effector proteins like EEA1 and the 
membrane remodelling ESCRT complexes, which drive the progression of early 
phagosomes to the degradative lysosomal pathway to eliminate the pathogen5. For 
Mtb infection, two secreted phosphatases have been implicated in subverting PI 
metabolism in the host to promote intracellular survival, MptpB6,7,8 and SapM9,10. 
 
SapM, was initially described as a nonspecific acid phosphatase11, and later reported 
to dephosphorylate PI3P9 a central player in phagosomal maturation12,13. Studies 
involving sapM deficient Mtb mutants supported a role for this protein in phagosome 
maturation arrest10,14 by preventing Rab5-Rab7 exchange15. In addition, SapM 
appears to have a role in immunogenicity14,16,17 and autophagy inhibition18. Notably, 
deletion of the sapM gene attenuated Mtb intracellular growth in human and mouse 
macrophages10,14 and reduced the mycobacterial burden in guinea pig models of 
infection10. However, deletion of sapM did not affect mycobacterial growth in 
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extracellular cultures10 thus confirming its role as a virulence factor important for 
intracellular mycobacterial survival.  
 
The growing evidence on the importance of SapM in pathogenesis makes it an 
attractive drug target for TB therapy, particularly since antivirulence drugs are 
gathering momentum as new therapeutic approaches to fight antimicrobial 
resistance8,19,20,21. However, the molecular mechanism of catalysis and mode of action 
of SapM is still largely unknown. This knowledge is crucial to fully exploit its potential 
as a pharmacological target, and to guide the design of specific inhibitors for drug 
development. To date a full biochemical and kinetics characterisation of this 
phosphatase has not been possible due to challenges in producing recombinant 
SapM. We have now successfully expressed SapM in E. coli and purified it to 
homogeneity for enzymatic profiling and inhibition studies. The enzyme kinetics 
analysis and mutagenesis of conserved residues, indicates that SapM follows a 
serine-based mechanism of catalysis similar to alkaline phosphatases. The substrate 
specificity and inhibition profiles for SapM show differences with classical alkaline 
phosphatases indicating that SapM is an atypical member of this family.  
 
In addition, we provide evidence of SapM activity towards a wide range of PIs with 
preference for PI(4,5)P2 and PI3P. This suggests a potential new role for this 
phosphatase in pathogenesis by acting at the early stages of phagocytosis as well as 
in phagosomal maturation. Finally, we report that 2-phospho-L-ascorbic acid (2P-AC) 
is a competitive inhibitor of SapM and that reduces intracellular survival of Mtb in 
infected macrophages. This is the first evidence that inhibition of SapM could be 
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exploited to control Mtb infection and underlines the potential for anti-virulence 
approaches to develop new therapies to treat TB. 
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Results 
SapM shares conserved functional residues with acid and alkaline 
phosphatases. 
Bioinformatics approaches were used to analyse the sequence of SapM and related 
proteins. A BLAST search revealed orthologues of SapM in all mycobacterial species 
with 70-99% pairwise identity (Fig. 1A). SapM-related sequences were also found in 
other bacterial and fungal organisms, although with lower identity (30-50%). Most of 
these proteins are currently annotated either as hypothetical proteins, uncharacterised 
or acid phosphatases, but their catalytic mechanism is unknown. These searches did 
not identify related sequences in higher eukaryotes.  
InterPro analysis showed that SapM possesses a signature match to the 
phosphoesterase domain that is present in the superfamily of alkaline 
phosphatases22,23 and in the superfamily of acid phosphatases and phospholipases C 
(PLC/phosphatase superfamily)24. A prototype of classic alkaline phosphatases 
(AlkPs) is the Escherichia coli alkaline phosphatase (Ec-AlkP)25, which shares 23% 
sequence similarity (16% identity) to SapM (Fig. 1A). Likewise, a well-characterised 
member of the PLC/phosphatase superfamily, the Francisella tularensis AcpA (Ft-
AcpA), with a 3D structure similar to alkaline phosphatases26, shares 25% sequence 
similarity (15% identity) to SapM.  
The low pairwise identity values made difficult a direct assignment of this enzyme to 
any of these families, but a multiple sequence alignment with representatives across 
the different superfamilies and the SapM-related sequences (Fig. 1A) highlighted the 
conservation within the phosphoesterase domain, of residues essential for catalysis 
and substrate binding in Ft-AcpA26,27, and Ec-AlkP25. This conservation includes the 
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nucleophile serine (S175 in Ft-AcpA and S102 in Ec-AlkP), metal binding and 
substrate binding residues (Fig. 1A). Thus, the analysis suggested that SapM may 
share a similar serine-based, potentially metal-dependent, mechanism of catalysis 
with these enzymes, despite the modest overall conservation. To elucidate the 
catalytic mechanism of SapM, we carried out a comprehensive biochemical and kinetic 
characterisation of the enzyme.  
 
The optimal enzymatic activity for SapM is at a basic pH 
The SapM mature secreted native protein comprises residues 44 to 29911, which 
contains the whole phosphoesterase domain (Fig. 1B). A construct with a His-tagged 
version of the mature sequence was expressed in E. coli C41 (DE3), taking advantage 
of the periplasmic localisation sequence provided by the pET22b vector (Novagen). 
Soluble SapM was successfully obtained after treatment of the bacterial cell pellet with 
the ionic surfactant sarkosyl28 (see methods for details). Subsequently, purification by 
nickel-affinity chromatography produced 95% pure protein (Fig. 2A). SapM migrates 
according to the predicted molecular weight of 28.8 kDa for the mature protein plus 
the His6-tag (as calculated in ProtParam29). The identity of the purified protein was 
confirmed by tryptic digestion followed by LC/MS/MS analysis, and the intact mass 
calculated as 28,772.3 ± 0.19 Da. To the best of our knowledge, this is the first report 
of SapM being produced as a soluble recombinant protein following expression in E. 
coli.   
Next, we evaluated the enzymatic activity of the purified SapM protein by measuring 
the conversion of p-Nitrophenyl phosphate (pNPP) into p-nitrophenol at different pH 
values and in the presence or absence of dithiothreitol (DTT). The optimal activity for 
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SapM was obtained at pH 7.5 in the absence of DTT (Fig. 2B). We also confirmed the 
optimal activity at this pH for the protein after cleavage of the His-tag (Suppl. Fig. 1). 
This is in agreement with the enzyme activity pH range (6.5-7.5) reported for the native 
SapM11. 
The addition of 3 mM DTT resulted in a considerable reduction of the specific activity 
at any pH, with a drop of activity of about 70% at pH 7.5 (Fig. 2B). Usually, DTT is 
used to prevent disulfide bond formation by reduction of Cys residues, which is 
particularly critical in Cys-based phosphatases where oxidation of the catalytic 
cysteine abolishes enzyme activity30. However, SapM protein lacks the hallmark active 
site P-loop motif (CX5R) present in Cys-based phosphatases31. Therefore, the effect 
of DTT potentially suggests a different mechanism in reducing enzyme activity. DTT 
can also act as a metal chelator due to its ability to form stable coordination complexes 
with metals32,33. Since the metal-binding residues identified in Ft-AcpA and Ec-AlkP 
are conserved in SapM, a potential explanation would be that the effect of DTT is due 
to chelation of a bound metal. Alternatively, DTT may impact on a metal oxidation 
state, which could similarly result in metal dissociation. These findings are therefore 
consistent with the suggestion that SapM is also a metal-dependent enzyme.  
 
Mutagenesis of conserved residues suggests an alkaline-like mechanism of 
catalysis 
Our bioinformatics analysis showed that SapM shares conserved catalytic residues 
with Ec-AlkP and Ft-AcpA (Fig. 1A), both of which also follow an alkaline mechanism 
of catalysis25,26. Ft-AcpA and Ec-AlkP both use a serine (S175 in Ft-AcpA and S102 
in Ec-AlkP) as the nucleophile, which is activated by metal ions, three in the case of 
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Ec-AlkP (two Zn2+ and Mg2+)25,34 and only one in the case of Ft-AcpA26. The crystal 
structure of Ft-AcpA in complex with vanadate26 revealed four histidines (H106, H287, 
H288 and H350) critical for substrate binding. In the Ft-AcpA structure the metal ion is 
coordinated by seven oxygen atoms from residues N44, E43, D386, D387 and the 
vanadate molecule (Fig. 3A). Key catalytic residues in Ft-AcpA are also present in the 
structure of Ec-AlkP25 (Fig. 3A). Based on the multiple sequence alignment, up to eight 
residues important in Ft-AcpA catalysis and substrate binding are conserved in SapM 
(Fig. 1A, 3A).  
We explored the role of these conserved residues in SapM, by mutagenesis and 
enzyme activity assays. The SapM mutants S95A, N60A, E59A, D238A, E239A, 
H160A and H204A exhibited no activity towards pNPP, even at longer incubation times 
of up to 90 min (Fig. 3B). Using the catalytic mechanism described for Ft-AcpA as a 
reference, we propose S95 to act as the nucleophile in SapM.  Residues E59, N60, 
D238 and E239 align with the metal-binding site described for Ft-AcpA, and an 
analogous role in metal-binding is supported by their requirement for SapM-mediated 
catalysis. The residues H160 and H204 may be involved in substrate binding as their 
cognate residues H288 and H350 in Ft-AcpA. In fact, mutation of Ft-AcpA H288 and 
H350 to alanine, also resulted in lack of enzyme activity in that enzyme27. 
Interestingly, the SapM K159A mutant showed only reduced activity towards pNPP 
with respect to the wild-type enzyme (Fig. 3B), indicating that it is important but not 
essential for catalysis. Analogous residues H287 in Ft-AcpA27 and R166 in Ec AlkP25, 
appear to have a role in substrate binding as well. Our mutagenesis studies thus 
confirmed the importance of the conserved residues S95, N60, E59, D238, E239, 
H160, H204 and K159 in SapM catalysis and substrate binding. These data and the 
proposed role for these residues indicate that SapM follows a serine-based alkaline-
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like mechanism of catalysis similar to that of Ec-AlkP and Ft-AcpA with S95 acting as 
the nucleophile.  
 
Influence of metal ions in SapM enzymatic activity  
In order to study the potential role of metal ions in SapM activity, we performed 
enzymatic assays in the presence of a range of transition (Co2+, Ni2+, Zn2+, Mn2+, 
Cu2+and Fe3+) and alkaline metals (Ca2+ and Mg2+). The activity of SapM was totally 
inhibited by zinc, and reduced by >50% in the presence of copper, cobalt and nickel. 
Magnesium was the only metal that did not affect the enzymatic activity of SapM (Fig. 
4A). Next, using electron paramagnetic resonance (EPR) spectroscopy, we tested for 
the presence of Fe3+, Zn2+, Mn2+, Cu2+. No signal for any of these metal ions was 
detectable, indicating that none of these metals are bound to the enzyme under the 
conditions tested. We also carried out inductively coupled plasma mass 
spectrometry (ICP-MS) analysis of purified SapM, which failed to detect the presence 
of protein associated metals (Mg, Ca, Cr, Co, Ni, Cd, Cu, Zn or Fe). Thus, whilst none 
of these metals are co-purified with SapM, it remains possible that they can bind to 
SapM and inhibit activity by displacing an as yet unidentified metal-cofactor. It is 
noteworthy that these experiments were repeated with SapM purified with EDTA-free 
buffers (including lysis buffer), but the results were unchanged. 
High concentrations of DTT (10 mM) completely inhibited SapM activity (Fig. 4B), 
supporting the idea that DTT may be acting (chelating or changing oxidation state) on 
a unknown metal that is resistant to high concentrations (10 mM) of the divalent 
chelators ethylenediaminetetraacetic acid (EDTA) and egtazic acid (EGTA) (Fig. 4B).  
SapM is an atypical monoester alkaline phosphatase 
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Next, we tested a wide range of phospho-substrates to establish the specificity of 
SapM. SapM hydrolysed a wide range of different phospho-substrates and fifteen of 
them with a specific activiy of at least 50% with respect to pNPP (Fig. 5A), indicating 
a broad specificity. Kinetic analysis of the best substrates showed that SapM displays 
the highest efficiency (kcat/Km) towards the triphosphate nucleosides ATP and GTP 
(Fig. 5B). SapM also hydrolysed cysteamine S-phosphate, a substrate for classic 
alkaline phosphatases35, with a specific activity of 57% with respect to pNPP hydrolisis 
(Fig. 5A). 
 
The activity of SapM towards the phosphodiester substrates bis-p-nitrophenyl 
phosphate (Bis pNPP) and adenosine 3′,5′-cyclic monophosphate (c-AMP), typical 
substrates of phosphodiesterases36,37, was less than 5% with respect to pNPP 
hydrolisis. SapM therefore shows a clear preference for phosphomonoesters over 
phosphodiester substrates, ruling out that it functions as a phosphodiesterase.  
 
Next we tested common inhibitors of protein phosphatases. The oxyanions, vanadate 
and molybdate, which are inhibitors of classic phosphotyrosine phosphatases 
(PTPs)38, abolished SapM activity (Fig 4B). High concentrations (10 mM) of 
tetramisole hydrochloride, an alkaline phosphatase inhibitor35, did not inhibit the 
enzyme activity. Likewise, SapM activity was resistant to sodium fluoride (acid 
phosphatase inhibitor) and sodium tartrate (acid phosphatase and Ser/Thr 
phosphatase inhibitor) (Fig. 4B). These findings suggest a mixed type of inhibition 
profile for SapM matching neither classic acid phosphatases, nor alkaline 
phosphatases. 
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The broad substrate specificity of SapM, together with the optimal pH of 7.5 is similar 
to that observed in the alkaline phosphatase family. However, SapM shares only 16% 
identity with the closest classical alkaline phosphatase, Ec-AlkP, and lacks the 
characteristic catalytic motif present in alkaline phosphatases, DSA (D101, S102 and 
A103 in Ec-AlkP), where S is the nucleophile residue25. Instead, SapM has a PSE 
motif, conserved in all mycobacterium orthologues and microbial related sequences 
(Fig. 1A), which contains the catalytic S95.  
 
Previous studies suggested that SapM could be a nonspecific acid phosphatase 
(NSAP) or a His-based phosphatase11. Our analyses indicate that SapM does not 
contain the characteristic motifs found in His-based phosphatases, such as the 
catalytic RHGXRXP motif39, where the histidine is the nucleophile. SapM is also 
missing the conserved active site motif CX5R of acid phosphatases31, and does not 
present any of the characteristic motifs of NSAP described up to now40. These data, 
together with the identification of the catalytic residues, indicate that SapM behaves 
as an atypical alkaline phosphatase with broad monoesterase activity.  
 
SapM shows specificity for PI(4,5)P2 and PI3P 
Previous studies9 suggested that the native SapM was able to dephosphorylate mono-
phosphorylated phosphoinositides (PIs), specifically PI3P. However, nothing was 
reported about SapM activity towards the di and tri-phosphorylated PIs. Surprisingly, 
the isolated SapM can hydrolyse a wide range of phosphoinositides (Fig. 6A), but 
preferentially dephosphorylates PI(4,5)P2 and PI3P, showing higher kcat/Km values 
over the rest. In contrast, SapM shows 5 to 10 times lower catalytic efficiency towards 
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the mono-phosphorylated PI4P and PI5P due to a much lower affinity (Km) for these 
compounds (Fig. 6B).  
Interestingly, the K159A mutant showed less than 2% activity towards PI(4,5)P2, and 
PI3P whilst retaining 21% and 13% activity for pNPP and ATP, respectively (Fig. 6C). 
Kinetic analyses also revealed a 2-fold increase in Km and a 10-fold decrease in kcat/Km 
for K159A towards ATP (Fig. 6D), confirming its role in substrate binding as proposed 
for its analogues H287 in Ft-AcpA27 and R166 in Ec-AlkP41. Hence, similarly to R166 
in Ec-AlkP25, K159 may provide additional stabilisation of the negatively charged 
phosphosubstrates, which is clearly critical for hydrolysis of phosphoinositides that 
contain extra negatively charged phosphate groups.  
The specificity of SapM for PI(4,5)P2 in addition to PI3P is intriguing and suggests that 
this phosphatase may have more than one role in infection and pathogenesis, since 
these PIs localise to the plasma/phagocytic membrane and early phagosome 
membrane, respectively. 
 
Inhibition of SapM enzymatic activity 
Inhibition studies indicated that L-ascorbic acid (L-AC) and 2-phospho-L-ascorbic acid 
(2P-AC) inhibit the enzymatic activity of Ft-AcpA27. Since SapM shares a similar 
mechanism of catalysis with Ft-AcpA, we speculated that these compounds may also 
inhibit SapM. An initial test showed that 10 mM of L-AC and 2P-AC completely 
abolished the enzyme activity of SapM. Subsequently we determined the IC50 to be 
241 µM for L-AC and 234 µM for 2P-AC (Fig. 7A, B). The mechanism of inhibition by 
these compounds differs. L-AC acts as uncompetitive inhibitor as noted by variations 
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of the Vmax and the Km at different inhibitor concentrations (Fig. 7C). L-AC is a potent 
oxidant and thus its inhibition may be the result of metal oxidation in the enzyme-pNPP 
complex42, explaining the uncompetitive mechanism of inhibition observed.  In 
contrast, 2P-AC behaves as a competitive inhibitor, since variations in its 
concentration produced marked changes in the Km while the Vmax remained 
unchanged (Fig. 7D). Since SapM can also hydrolyse 2P-AC (Fig. 5), this compound 
may inhibit SapM activity in a two-way mechanism: by competing with pNPP for 
binding to the active site, and as a metal oxidant, as a result of its ascorbic acid 
production due to hydrolysis.  
 
 2-phospho-L-ascorbic acid reduces survival of M. tuberculosis in infected 
macrophages, although does not affect extracellular growth  
Next, we evaluated the effect of these SapM inhibitors on Mtb extracellular growth. 
For this, growth of the Mtb H37Rv strain was monitored over the course of 11 days 
(Fig. 8A) with and without the addition of the inhibitors. Cultures were treated with 
different concentrations of L-AC and 2P-AC added in day 0 and 1, and growth was 
monitored using optical density (OD600). Mycobacterial growth was severely reduced 
from day 2 with 4 mM L-AC, and even a lower concentration (1 mM) L-AC had a 
significant (p=0.0039) effect in growth reduction (Fig. 8A). These findings are in 
agreement with previous studies showing the effect of L-AC on mycobacterial 
growth43. In contrast, treatment with 1 mM 2P-AC did not affect mycobacterial growth 
(Fig. 8A), while treatment with 4 mM 2P-AC showed only significant reduction of 
mycobacterial growth from day 7 (p=0.0048). The delayed effect of 2P-AC may be due 
to slow spontaneous hydrolysis in solution of the phosphate group to generate 
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ascorbic acid, as previously reported44, plus hydrolysis by the secreted SapM. Thus, 
while L-AC shows a severe effect on inhibiting Mtb extracellular growth, the presence 
of the phosphate group in 2P-AC appears to have a protective effect, during the first 
7 days post-treatment.  
Previous studies have demonstrated that deletion of the sapM gene, results in 
reduction of mycobacterial burden within macrophages and guinea pig models of 
infection10,14,15. We hypothesised that chemical inhibition of SapM may recapitulate 
the effect of the sapM knockout, thus reducing intracellular mycobacterial survival. To 
test this, we assessed the efficacy of 2P-AC in reducing Mtb (H37Rv) survival in resting 
human THP1 macrophages. We observed a significant (p=0.0365) reduction in 
bacterial burden at 72 h post-infection of 39% upon treatment with 4 mM 2P-AC 
compared to the non-treated control (Fig. 8B). Control experiments showed that 2P-
AC has no detrimental effect on macrophage viability (Fig. 8B inset). In addition, 
inhibition of 2P-AC is specific for SapM, as it did not inhibit the other secreted 
mycobacterial phosphatases MptpA and MptpB when tested at 4 mM concentration. 
Importantly, 2P-AC showed no effect on extracellular cultures of Mtb at 72 h, therefore 
the reduction in bacterial burden observed is consistent with the proposed role of 
SapM in mycobacterial intracellular survival10,14. These findings demonstrate that 
SapM inhibition may be effective in assisting mycobacterial clearance during infection, 
thus providing a novel mechanism of action for TB treatment. 
 
Discussion  
In this study, we provide new insights into the mechanism of catalysis, substrate 
specificity and inhibition of SapM. Our findings demonstrate that SapM is an atypical 
monoester alkaline phosphatase, with a serine-based mechanism of catalysis 
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probably metal-dependent. Particularly relevant to SapM function and pathogenesis, 
is its activity towards PI(4,5)P2 and PI3P, two PIs that act at the early stages of 
microbial phagocytosis and phagosome formation. This suggests that SapM may have 
a pleiotropic role with a much wider impact on Mtb infection than initially thought. 
Finally, we have identified two inhibitors of SapM, 2P-AC and L-AC, which define two 
different mechanisms (competitive and metal oxidation) by which the catalytic activity 
of this phosphatase could be regulated. Critically we demonstrate that 2P-AC reduces 
mycobacterial survival in macrophage infections.  
Our bioinformatics analysis revealed that SapM and orthologues share a conserved 
phosphoesterase domain with the superfamily of alkaline phosphatases (Fig. 1A). 
Consistent with this, we have demonstrated that SapM is a monoester phosphatase 
capable of hydrolysing a broad range of phosphosubstrates including cysteamine S-
phosphate, an alkaline phosphatase substrate, and ATP for which the enzyme showed 
the highest specificity (Fig. 5A, B). Based on the multiple sequence alignment and 
using mutagenesis and activity assays, we have identified for the first time the key 
catalytic residues of SapM, including the nucleophile S95 and residues (E59, N60, 
D238 and E239 H160 and H204) which are associated with metal and substrate 
binding (Fig. 3A, B). Furthermore, we have identified Lys159, as critical for 
phosphoinositide binding (Fig. 6C, D).  
SapM shares a similar mechanism of catalysis with another phosphatase, Ft-AcpA, 
which is critical for survival of F. tularensis in host cells. Inhibition of Ft-AcpA with 2P-
AC impaired survival of F. tularensis in infected macrophages27. We have 
demonstrated in this study, that 2P-AC is a competitive inhibitor of SapM (Fig. 7D) with 
efficacy in reducing mycobacterial burden in infected macrophages, despite having no 
effect on extracellular bacterial cultures (Fig. 8A, B). We expect that more potent 
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inhibitors, perhaps based on the 2P-AC scaffold, would provide good starting points 
for drug development and further validation of SapM as a drug target.  
Manipulation of the host phosphoinositide metabolism is a common mechanism in 
microbial pathogenesis to promote colonisation of macrophages during 
infection4,5,45,46. This is particularly relevant for Mtb infections where alteration in PI 
dynamics affects phagosomal maturation and enables long-term survival of the 
bacteria in alveolar macrophages. We show in this study that SapM is able to 
hydrolyse all seven phosphoinositides albeit with higher specificity for PI(4,5)P2 and 
PI3P, and to our knowledge, SapM is the first bacterial phosphatase to show such a 
broad PI activity.  
Previously, another two secreted phosphatases, MptpA and MptpB, have been 
implicated in the regulation of phagosomal maturation by Mtb8,47,48,49. Based on the 
current knowledge and our new data on the activity of SapM, we propose a model in 
which these three mycobacterial phosphatases MptpA, MptpB and SapM, could be 
acting in a coordinated manner to control phagosome biogenesis, acidification and 
maturation, blocking phagolysosome fusion and thus promoting survival of Mtb in the 
macrophage (Fig. 9). 
The role of Mtb in phagosome maturation arrest is a complex mechanism where many 
players take part at different stages5 (Fig. 9). Initial phagosome formation and scission 
from the plasma membrane requires hydrolysis of PI(4,5)P250. This is a critical step for 
pathogenic invasion as described for Salmonella51 and Yersinia52. In this context, 
PI(4,5)P2 hydrolysis by SapM could represent a critical step to facilitate Mtb uptake 
and colonisation of the host.  
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The early phagosome membrane is characterised by the presence of PI3P critical for 
phagosomal maturation downstream events5,9. Hydrolysis of PI3P by SapM has been 
implicated in phagosome maturation arrest9. We have previously reported that MptpB, 
also dephosphorylates PI3P49, and that inhibition of MptpB, affects PI3P dynamics in 
infected macrophages8. Hence, it is probable that the combined hydrolysis of PI3P by 
both SapM and MptpB enhances maturation arrest at this early stage. MptpB also 
dephosphorylates PI(3,5)P249, a key lipid for late phagosome formation and fusion to 
lysosomes53. 
Another critical event that promotes Mtb survival is the prevention of phagosome 
acidification. Acidification is triggered by V-ATPase (proton-pumping ATPase) 
recruitment, which requires ATP to translocate protons (H+) creating the acidic 
environment inside the phagosome54. MptpA inhibits V-ATPase trafficking to the 
mycobacterial phagosome by dephosphorylation of VPS33B (human vacuolar protein 
sorting 33B)47, thus preventing acidification. Since SapM hydrolyses ATP with high 
efficiency, this could also contribute to prevent acidification. Therefore, arrest of 
phagolysosomal fusion and subsequent bacterial destruction may be controlled by the 
coordinated activities of these three secreted phosphatases to enhance mycobacterial 
survival in the host (Fig. 9). Testing this model and the spatio-temporal involvement of 
three Mtb phosphatases in phagosome maturation and PI dynamics will be the focus 
of future work. 
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Material and Methods  
Bioinformatics analysis 
BLAST searches in the UniProt Knowledgebase (UniProtKB)55, were performed using 
the full length sequence to identify SapM-related sequences. Next, using InterPro 
database56 conserved domains and families were identified57. For the BLAST 
searches, the E-Threshold was set at two values: 0.0001 and 10. Multiple sequence 
alignments were performed using Clustal Omega58 and manually edited using the 
program Jalview Version 2.10.3b159. 
 
Cloning and mutagenesis of SapM  
The open reading frame of Rv3310, encoding the SapM gene, was amplified from 
Mycobacterium tuberculosis (Mtb) H37Rv DNA. The amplicon from residues 44 to 299,  
corresponding to the mature protein11 was cloned into pET22b (Novagen) vector using 
the forward (5’-GCTGCTCCATGGCGAGTGCCCTGCCGACC-3’) and reverse (5’- 
GCTCGTGCGGCCGCGTCGCCCCAAATATCGGTTATTGG-3’) primers containing 
NcoI and NotI restriction sites (New England Biolabs, UK) to generate the C-terminal 
His6-tagged SapM construct. Site directed mutagenesis was carried out using 
AccuzymeTM DNA Polymerase (BIOLINE) for thermal cycling and the PCR product 
inserted into pET22b vector. The His6-tagged SapM construct was used as a template. 
DNA sequence analyses confirmed that residues E59A, N60A, S95A, K159A, H160A, 
H204A, D238A and E239A were mutated and that no additional changes were 
introduced.  
 
Mechanism of catalysis and inhibition of SapM  Fernandez-Soto et al. 
 21 
Overexpression and purification of recombinant SapM 
Constructs (wild-type and mutants) were transformed into Escherichia coli C41 (DE3) 
strain for expression of recombinant proteins. Single colonies of E. coli C41 (DE3) 
were inoculated in 10 ml of LB (Luria-Bertani) broth supplemented with ampicillin (100 
µg/ml) and 1% glucose and incubated overnight. Subsequently the overnight culture 
was diluted into 400 ml of auto-induction media60 and grown at 37°C with shaking (220 
rpm) until OD600 reached ~0.4. The culture temperature was reduced at 20 °C for 
protein expression and culture was harvested (6500 g for 15 min at 4 °C) 24 h later. 
Recombinant SapM (wild-type and mutants) was purified by nickel-affinity 
chromatography using an AKTA purification system (GE Healthcare). Cell pellets were 
re-suspended in lysis buffer containing 50 mM HEPES, 500 mM NaCl, with 1 mM 
ethylenediaminetetraacetic acid (EDTA), 1 mg/ml lysozyme, 1% N-lauroylsarcosine 
sodium salt (sarkosyl) (Sigma-Aldrich), 38 units/ml of benzonase nuclease (Sigma-
Aldrich) and complete EDTA-free protease inhibitor cocktail (Roche), pH 7 and 
incubated on ice for 30 min. Cells were disrupted by sonication (Sonics Vibra-Cell). 
Lysates were cleared by centrifugation at 12,000 g for 1 h at 4 °C. The cell lysate was 
filtered through a 0.45 µm flask filter and loaded onto a 1 ml HisTrapTM HP column 
(GE Healthcare) in binding buffer containing 50 mM HEPES, 500 mM NaCl and 0.05% 
sarkosyl, pH 7 and washed with buffer containing 50 mM HEPES, 500 mM NaCl and 
0.05% Sarkosyl, and 60 mM imidazole, pH 7. Protein was eluted with a gradient of 
imidazole (from 60 mM to 250 mM) in the elution buffer. Fractions containing the 
protein were further purified using a second 1 ml HisTrapTM HP column and eluted with 
200 mM imidazole in elution buffer (50 mM HEPES, 500 mM NaCl and 0.05% 
Sarkosyl). Purity of fractions was verified in a coomassie-stained 10% SDS-PAGE run 
under reducing conditions with beta-mercaptoethanol. The identity of SapM was 
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confirmed by trypsin digestion and mass spectrometry (LC/MS/MS) using a sample 
protein excised from an acrylamide gel corresponding to the second IMAC purification. 
Multiangle light scattering analysis confirmed a molecular mass of 30.3 kDa and that 
the sample was monodisperse after IMAC purification. 
 
Overexpression and purification of MptpA and MptpB.  
The N-terminal histidine tagged constructs for MptpA and MptpB were generated as 
previously described7,8. Constructs were transformed into E. coli BL21(DE3) and 
expression induced at 18 °C with 0.5 mM IPTG (isopropyl-β-D-thiolgalactopyranoside) 
for MptpB and  0.1 mM IPTG for MptpA for 16 h. Purification of both MptpA and MptpB 
was done by nickel affinity chromatography followed by a size exclusion 
chromatography using a Superdex75 (10/300) column  (GE Healthcare). MptpB and 
MptpA proteins were eluted in buffer containing 20 mM Tris-Base, 150 mM NaCl, 3 
mM EDTA, pH 7.  
 
Activity assays using p-Nitrophenyl phosphate (pNPP) 
Enzymatic activity of SapM was assessed by hydrolysis of p-Nitrophenyl phosphate 
(pNPP) (Sigma-Aldrich) according to the manufacturer’s protocol. Briefly, we tested 
pH ranges 4 to 6, using a 150 µl reaction mixture containing 0.5 µg protein, 1 mM 
pNPP in 50 mM Tris-Base, 150 mM sodium acetate with/without 3 mM dithiothreitol 
(DTT) and pH ranges 7 to 9.5 in 50 mM Tris-Base, 150 mM NaCl and with/without 3 
mM DTT. Samples were incubated at 37 °C for 30 min at which time the reaction was 
quenched by adding 50 µl of NaOH 1 M. The absorbance was subsequently read at 
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405 nm using a Multiskan® Spectrum spectrophotometer (Thermo Scientific). The 
concentration of p-nitrophenol produced was determined using a p-nitrophenol 
standard curve (15 µM – 2000 µM of Sigma-Aldrich p-nitrophenol standard solution). 
Optimal pH was tested using the His6-tagged and naked SapM protein (without the 
tag). The assay was optimized with respect to time and protein concentration so that 
the reaction is performed within the linear range of the initial velocity. 
The effect of metals and inhibitory compounds were tested using a 150 µl reaction 
mixture containing 1 µg of protein in 50 mM Tris-Base, 150 mM NaCl, pH 7.5 and the 
different metals or inhibitory compounds (metals and inhibitory compounds at 10 mM, 
except FeCl3 at 1 mM) and incubated for 30 min at room temperature, followed by the 
addition of pNPP to a final concentration of 500 µM and further incubated for 30 min 
at 37 °C. The reaction was quenched by adding 50 µl of NaOH 1 M followed by the 
steps explained above. Metals and compounds sodium tartrate (Na-Tr), egtazic acid 
(EGTA), sodium fluoride (NaF), 2-phospho-L-ascorbic acid (2P-AC), sodium 
orthovanadate (Na-OV), sodium molybdate (Na-Mb), L-ascorbic acid (L-AC) were all 
from Sigma-Aldrich. EDTA, (Fisher Scientific) and tetramisole hydrochloride (THC) 
(Fluorochem). 
The phosphatase activity of SapM  (wild-type and mutants) was determined using a 
150 µl reaction mixture containing 0.5 µg of protein and 1 mM pNPP  in 50 mM Tris-
Base, 150 mM NaCl, pH 7.5 and incubated at 37 °C for 30 min , 60 min and 90 min. 
The absorbance was read at 405 nm every 30 min after quenching the reaction. 
Concentration was calculated as explained above. All the experiments were performed 
in triplicates in 96-well microplates F-bottom clear plates (Greiner bio-one) in at least 
two separate studies. 
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Activity assays using the Malachite Green Assay 
The amount of free phosphate during the dephosphorylation of phosphosubstrates 
was determined with the malachite green assay (Sigma-Aldrich) according to the 
manufacturer’s protocol. The substrates tested were: phosphoinositide substrates 
diC8-PI3P, diC8-PI(3,4)P2, diC8-PI(3,5)P2, diC8-PI4P, diC8-PI(4,5)P2, diC8-PI5P, and 
diC8-PI(3,4,5)P3 (all from Echelon Bioscience), O-phospho-L-tyrosine (P-Tyr), O-
phospho-L-serine (P-Ser), O-phospho-L-threonine (P-Thr), cysteamine S-phosphate 
sodium salt (CysS-P), bis-(p-nitrophenyl) phosphate sodium salt (Bis pNPP), 
phosphorylcholine chloride (PC), O-phosphorylethanolamine (PETh), mono-sodium 
phosphoenolpyruvate hydrate (PEP), glycerophosphate disodium salt hydrate (GlyP), 
inosine 5′-monophosphate disodium salt hydrate (IMP), guanosine 5′-monophosphate 
disodium salt hydrate (GMP), guanosine 5′-triphosphate sodium salt hydrate (GTP), 
adenosine 5′-triphosphate (ATP) disodium salt hydrate, adenosine 5′-diphosphate 
sodium salt (ADP), adenosine 5′-monophosphate disodium salt (AMP), trehalose 6-
phosphate dipotassium salt (T6P), D-fructose 6-phosphate disodium salt hydrate 
(F6P), phytic acid (PhyA), α-Naphthyl phosphate (α –NP), β-nicotinamide adenine 
dinucleotide 2′-phosphate reduced tetrasodium salt hydrate (NADPH), riboflavin 5′-
monophosphate sodium salt hydrate (FMN), adenosine 3′,5′-cyclic monophosphate 
sodium salt monohydrate (c-AMP), D-Glucose 6-phosphate sodium salt (G6P) (all 
from Sigma-Aldrich), and adenosine 5'-monophosphate sodium salt (AMP) (Fisher 
Scientific). 
The specific activity of SapM towards the 34 substrates was determined using a 100 
µl reaction mixture containing reaction buffer (50 mM Tris-Base, 150 mM NaCl, pH 
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7.5), 80 µM of substrate and 1 µg of protein. The reaction mixtures were incubated at 
37 °C for 30 min prior to the addition of 15 µl of malachite green reagent. 
Subsequently, the reaction was further incubated for 15 min at room temperature (21 
°C). The absorbance was read at 620 nm using a Multiskan® Spectrum 
spectrophotometer (Thermo Scientific). The concentration of free phosphate produced 
was determined using a phosphate standard curve (25 – 3000 pmol of Sigma-Aldrich 
phosphate standard solution).  
Specificity activity (wild-type and mutants) towards pNPP, ATP, PI3P and PI(4,5)P2 
was evaluated with 80 µM of substrate and 0.1 µg of protein. For kinetic measurements 
(wild-type and mutants), we used 3-750 µM of substrate and 0.1 µg of protein. 
Incubation was at 37 °C for 1 h. Following steps were the same as explained above. 
All the experiments were performed in triplicates in 96-well microplates F-bottom clear 
plates in at least two separate studies. 
 
Kinetic analysis 
The Michaelis-Menten kinetic parameters Vmax and Km were calculated using non-
linear regression fit in GraphPad Prism 7.01 for Windows by plotting velocity as a 
function of pNPP concentration. The kcat was determined by dividing the Vmax by the 
molar enzyme concentration. Values are calculated as average of at least two 
separate studies performed in triplicates with ± SEM.  
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EPR and ICP-MS studies  
Both analyses were performed using a sample containing ~4 mg/ml of protein in 200 
mM NaCl, 20 mM HEPES, pH 7 with and without EDTA present. For EPR, continuous‐
wave EPR spectra were recorded at 9.4 GHz (X‐band) on a Bruker EMX spectrometer 
equipped with a Super‐high‐Q rectangular cavity and an Oxford ESR‐900 liquid helium 
cryostat. Instrument operating conditions were modulation amplitude 4.0 G, 
modulation frequency 100 kHz, microwave power 0.3 mW, temperature 5.0 K. For 
ICP-MS, sample was treated with Nitric Acid 65 % and measured in an Agilent 7500 
ICP-MS (Agilent technologies, UK). The equipment was fitted with an auto sampler 
(ASX-500 series), a quartz double-pass spray chamber (Peltier-cooled, Scott-type), a 
concentric MicroMist nebuliser and a third generation Octopole Reaction System 
(ORS3). This allows for the correction of spectral interferences by the addition of He 
or H2 gas to the collision cell, producing ions of a lower kinetic energy that enable the 
analyte ions with a higher energy than the multipole to be transmitted to the mass 
analyser. The digested sample solution was added via a T-piece before nebulisation, 
along with the internal standard solution. Ion standards are made up from single stocks 
and mixed element standards supplied by VWR and Johnson Matthey. 
 
Inhibition assays 
The IC50 of 2-phospho-L-ascorbic acid (2P-AC) and L-ascorbic acid (L-AC) was 
determined using a 150 µl reaction mixture containing 0.5 µg of protein in 50 mM Tris-
Base, 150 mM NaCl, pH 7.5 and the different inhibitors (0.02 µM- 20 mM). The reaction 
was incubated for 30 min at room temperature, followed by the addition of pNPP to a 
final concentration equal to its Km value and incubated for 30 min at 37 °C. The reaction 
was quenched by adding 50 µl of NaOH 1 M to measure absorbance at 405 nm. The 
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concentration of p-nitrophenol produced was determined using a p-nitrophenol 
standard curve and expressed as a percentage of the specific activity. Data was 
plotted as a function of log inhibitor concentration to calculate the IC50 using a four-
parameter dose-response curve in GraphPad Prism 7.01. Selectivity assays for MptpA 
and MptpB were done by determining specific activity towards pNPP in the presence 
of 4 mM 2P-AC in a reaction assay containing 5 µg of protein, 50 mM Tris-Base, 50 
mM Bis-Tris, 100 mM Sodium Acetate, pH 6 and incubating for 30 min at room 
temperature. 
To determine the type of inhibition of 2P-AC and L-AC, different inhibitor 
concentrations were used (for L-AC 146 µM, 243 µM and 365 µM; for 2P-AC 140 µM, 
234 µM and 351 µM) in a 150 µl reaction mixture containing 0.5 µg of protein in 50 
mM Tris-Base, 150 mM NaCl, pH 7.5. Samples were incubated for 30 min at room 
temperature, followed by addition of different concentrations of pNPP (62.5 µM, 125 
µM, 250 µM, 500 µM, 1 mM and 2 mM) and further incubated for 30 min at 37 °C. The 
reaction was quenched by adding 50 µl of NaOH 1 M. Velocity (V) was plotted as a 
function of pNPP concentration and fit in a Lineweaver-Burk plot (double-reciprocal) 
using GraphPad Prism 7.01. All the experiments were performed in triplicates in at 
least two separate studies.  
 
Cell and bacterial culture conditions 
THP1 macrophages cells (ATCC) were cultured in Roswell Park Memorial Institute-
1640 medium (RPMI-1640) (R8758-Sigma-Aldrich) containing L-glutamine 
supplemented with 10% heat inactivated fetal bovine serum (FBS, Invitrogen) at 37 °C 
in a 5% CO2. M. tuberculosis (Mtb) laboratory strain H37Rv was grown on Middlebrook 
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7H9 broth (BD Diagnostics) at 37 °C in 5% CO2 or Middlebrook 7H10 agar (both 
mediums were supplemented with 0.05% Tween 80, 0.2% glycerol and 10% OADC). 
Mtb cultures were prepared using 1 ml of mid-log phase stock into 20 ml of fresh media 
and incubated static for 6 days prior to being used in infection assays or inhibitory 
assays. All experiments with Mtb were carried out in a biosafety level 3 containment 
facility. 
 
Extracellular growth of Mycobacterium tuberculosis and macrophage infections 
2-phospho-L-ascorbic acid (2P-AC) and L-ascorbic acid (L-AC) effect on extracellular 
cultures of Mtb was assessed by adding 1 mM or 4 mM of the compounds in 20 ml of 
Middlebrook 7H9 broth. Compounds were added to the culture in day 0 and 1 and 
allowed to grow over 11 days. Mycobacterial growth was monitored by optical density 
(OD) at 600 nm. Experiments were performed in triplicates in at least two separate 
studies. For statistical analyses, OD values were evaluated by two-way ANOVA 
followed by a multiple comparison analyses of variance by Bonferroni test (GraphPad 
Prism 7.01 for Windows). Differences were considered significant at the 95% level of 
confidence. 
 
For the macrophage infections, THP1 cells were seeded in 24-well culture plates 
(Corning) at a density of 1 x 105 cells per well (in 500 µl media) and treated with 200 
nM PMA for 2 h. After treatment, media was changed for fresh RPMI (with 10% FBS) 
overnight. The following day, media was removed and cells were washed with PBS 
and 500 µl of fresh RPMI was added containing 2P-AC (1 mM and 4 mM dissolved in 
water) before infecting the cells with Mtb at MOI of 5:1 (bacteria:macrophage). After 4 
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h of infection, THP1 cells were washed three times with Dulbecco’s PBS and fresh 
RPMI was added containing 2P-AC. After 24 h the media was removed and cells were 
washed twice with PBS prior to the addition of RPMI containing 2P-AC. At 72 h post 
infection cells were lysed with ice-cold water and plated onto 7H10 agar. Colonies 
were counted after 14 days. All experimental points were plated as 10-fold dilutions in 
triplicates. Each sample was setup in triplicates in at least two independent 
experiments. For statistical analyses, CFU/ml values were evaluated by one-way 
ANOVA followed by a multiple comparison analyses of variance by Bonferroni test 
(GraphPad Prism 7.01 for Windows). Differences were considered significant at the 
95% level of confidence. All experiments with Mtb were carried out in a biosafety level 
3 containment facility. 
 
Cytotoxicity assays 
MTT assay was performed as described previously61. Briefly, THP1 cells were seeded 
in 96-well culture plates (Corning) at a density of 5 x104 (in 200 l media) and treated 
with 200 nM PMA for 2 h. After treatment, media was changed for fresh RPMI (with 
1% FBS) and leaved it overnight. The following day media was removed and fresh 
RPMI was added supplemented with 2P-AC inhibitor. Inhibitor was added to each well 
at 0 h and 24 h. After 48 h, cells were washed once with PBS and 200 l of fresh RPMI 
was added. At 72 h, media was removed and changed for 200 l of fresh RPMI. Cell 
viability was assessed by adding 50 µl of filter sterilised MTT (5 mg/ml in PBS) to each 
well followed by a 2 h incubation period at 37 °C in a 5% CO2. Media was removed 
and the blue formazan crystals trapped in cells were dissolved by adding 200 µl of 
DMSO and 25 µl of Sorensen’s glycine buffer. The absorbance at 570 nm was 
measured in a plate reader. Each sample was setup in triplicates in at least two 
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independent experiments. 
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Figure 1. Sequence alignment and domain architecture of SapM. (A) Multiple 
sequence alignment showing the active site region of SapM orthologues and related 
sequences. Alignment is shaded blue according to sequence conservation 
(conservation is also given by numbers from 1 to 10, with 10 (*) being 100% 
conservation). Numbers above the alignment correspond to SapM residue numbering. 
The catalytic residues are denoted on red background with white letters. Gene names 
are included alongside with microbial pathogen names. Alignment was performed 
using Clustal Omega58 and figure with Jalview Version 2.10.3b159. Two asterisks 
denote pairwise identity. Black dots denote the catalytic motif in both SapM 
orthologues (PSE) and alkaline phosphatase (DSA). (B) Domain architecture of SapM 
with boundaries for the mature protein annotated. 
 
 
Figure 2. Expression, purification and enzymatic activity of SapM. (A) Coomassie 
stained 10% SDS-PAGE gel shows expression and purification of recombinant SapM 
(Mw 28.8 kDa) (lane E). Solubilisation was achieved using 1% sarkosyl in the lysis 
buffer. Purification was done by nickel-affinity chromatography and eluted with 200 
mM imidazole. U: uninduced, I: induced, TCE: total cell extract, P: pellet, S: soluble, 
W: wash, and E: elution. (B) Enzymatic activity of SapM was assessed using the p-
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Nitrophenyl phosphate (pNPP) assay. Hydrolysis of pNPP was measured at pH values 
ranging from 4 to 9 in the presence and absence of 3 mM dithiothreitol (DTT). Specific 
activity (SA) was calculated as nanomoles of p-nitrophenol (pNP) released per mg of 
protein and min of the reaction. Error bars represent standard deviation of the mean 
(SD) of triplicates.  
 
 
Figure 3. Identification of catalytic residues in SapM. (A) Schematic diagram 
showing the active site residues of AcpA from F. tularensis (Ft-AcpA in black). 
Conserved residues in SapM (in blue) and in the alkaline phosphatase from E. coli 
(Ec-AlkP in red) are shown. The metal ion has an octahedral coordination made of 
oxygens in AcpA and the vanadate that occupies the substrate-binding site 26. The 
underlined residues from Ec-AlkP occupy similar structural location with Ft-AcpA. 
SapM residues involved in metal binding (underlined in orange) and substrate binding 
(underlined in green) are highlighted. (B) Specific Activity (SA) of wild-type and 
mutants of the conserved residues in SapM measured by pNPP assay. Mutant K159A 
shows reduced activity with respect to the wild-type whereas the other mutations 
completely abolish the enzymatic activity of SapM (values overlap along the X-axis). 
Specific activity was calculated as nanomoles of p-nitrophenol (pNP) released per mg 
of protein and min of the reaction. Error bars indicate standard error of the mean (SEM) 
of two independent experiments. 
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Figure 4. Effect of metals and inhibitors on the enzymatic activity of SapM. 
Enzymatic activity of SapM was assessed using the pNPP assay. (A) SapM activity is 
tested in the presence of various metals (10 mM, except for FeCl3 that was used at 
1mM). (B) SapM activity was tested in the presence of 10 mM of metal chelators 
ethylenediaminetetraacetic acid (EDTA) egtazic acid (EGTA) and inhibitory 
compounds: orthovanadate (Na-OV) and sodium molybdate (Na-Mb), tetramisole 
hydrochloride (THC), sodium tartrate (Na-Tr), sodium fluoride (NaF) and dithiothreitol 
(DTT). Percentage of specific activity is calculated relative to the amount of p-
nitrophenol released from the hydrolysis of pNPP of the control (without metals or 
inhibitors). Error bars in A and B indicate SEM of two independent experiments. 
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Figure 5. Substrate specificity profile for SapM. Enzymatic activity of SapM protein 
was assessed using the malachite green assay. (A) SapM was tested for hydrolysis 
of phosphosubstrates at 80 µM. Percentage of specific activity is calculated relative to 
the amount of inorganic phosphate (Pi) released from the hydrolysis of pNPP 
substrate. Arrow highlights a substrate specific for alkaline phosphatases (AlkP). Error 
bars indicate SEM of three independent experiments. (B) Kinetic parameters for SapM 
dephosphorylation of substrates with specific activity >50% with respect to pNPP 
substrate. Values indicate SEM of two independent experiments. ATP (adenine 
triphosphate), G6P (glucose 6-phosphate), GTP (guanosine triphosphate), P-Tyr 
(phosphotyrosine), ADP (adenosine diphosphate), PEP (phosphoenolpyruvate), α –
NP (α-Naphthyl phosphate), 2P-AC (2-phospho ascorbic acid), AMP (adenosine 
monophosphate), F1,6bP (fructose 1,6-bisphosphate), NADPH (nicotinamide adenine 
dinucleotide 2′-phosphate reduced), P-Ser (phosphoserine), CysS-P (cysteamine S-
phosphate), FMN, (riboflavin monophosphate), F6P (fructose 6-phosphate), GMP 
(guanosine monophosphate), IMP (inosine monophosphate), GlyP 
(glycerophosphate), PEth (O-phosphorylethanolamine), T6P (threalose 6-phosphate), 
PhyA (phytic  acid), P-Thr (phosphothreonine), PC (Phosphorylcholine chloride), Bis 
pNPP (bis p-nitrophenyl phosphate), c-AMP (adenosine 3′,5′-cyclic monophosphate). 
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Figure 6. SapM hydrolyses phosphoinositides (PIs). Enzymatic activity of SapM 
protein was assessed using the malachite green assay. (A) SapM activity was tested 
on seven phosphoinositides at 80 µM. Percentage of specific activity is calculated 
relative to the amount of inorganic phosphate (Pi) released from the hydrolysis of 
pNPP substrate. (B) Kinetic parameters for SapM dephosphorylation of 
phosphoinositides. PI(3,4)P2 (phosphoinositide 3,4 di-phosphate), PI(3,4,5)P3 
(phosphoinositide 3,4,5 tri-phosphate), PI(4,5)P2 (phosphoinositide 4,5 di-phosphate), 
PI(3,5)P2 (phosphoinositide 3,5 di-phosphate), PI3P (phosphoinositide 3 phosphate), 
PI4P (phosphoinositide 4 phosphate), PI5P (phosphoinositide 5 phosphate). (C) The 
enzymatic activity of K159A mutant was tested on pNPP, ATP, PI(4,5)P2 and PI3P at 
80 µM. Specific activity was calculated as nanomoles of inorganic phosphate released 
per mg of protein and min of the reaction. (D) Kinetic analysis of the K159A towards 
ATP respect to the wild-type enzyme. Values and error bars in A, B, C and D indicate 
SEM of two independent experiments. 
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Figure 7. Mechanism of inhibition of SapM activity by L-ascorbic acid and 2-
phospho-L-ascorbic acid. Inhibition curves for L-ascorbic acid (L-AC) (A) and 2-
phospho-L-ascorbic acid (2P-AC) (B) using the pNPP assay. Percentage of specific 
activity is calculated relative to the amount of p-nitrophenol released in the absence of 
inhibitor. Lineweaver-Burk plots of SapM activity towards pNPP at increasing 
concentrations of L-AC (C) and 2P-AC (D). L-AC behaves as uncompetitive inhibitor 
as noted by variations of the Vmax and the Km at different inhibitor concentrations, 
whereas 2P-AC behaves as a competitive inhibitor as observed by changes of the Km 
while the Vmax remained unchanged at different inhibitor concentrations. Error bars in 
A, B, C and D represent SD of triplicates. 
 
Mechanism of catalysis and inhibition of SapM  Fernandez-Soto et al. 
 37 
Figure 8. Effect of L-AC and 2P-AC on Mycobacterium tuberculosis H37Rv 
growth. (A) The inhibitory effect of L-AC and 2P-AC on the extracellular growth of M. 
tuberculosis (Mtb) H37Rv was monitored by measuring optical density (OD600) over 
time. Cultures were treated with 1 mM or 4 mM of the inhibitors at day 0 and 1 and 
grown over 11 days. Statistical significance was evaluated by two-way ANOVA 
(Bonferroni test) where **p=0.0039; **p=0.0048; **p=0.0059; ***p=0.0010 and **** 
p<0.0001. Control is without inhibitor. (B) Effect of 2P-AC on intracellular Mtb survival 
in human THP1 macrophages. Significant reduction of mycobacterial growth 
(*p=0.0365 by one-way ANOVA, Bonferroni test) is observed at 4 mM compared to 
the control (without inhibitor). Plots represent the average of CFU/ml at 72 h post 
infection. Inset shows THP1 viability at 72 h upon treatment with 2P-AC. Error bars in 
A and B indicate SEM of two independent experiments. 
 
Figure 9. M. tuberculosis secreted phosphatases regulate phagocytosis and 
phagosome maturation. After target recognition pseudopodia extension is triggered 
by an increment of PI(4,5)P2 in the plasma membrane together with actin 
polymerization. Sealing of the phagosome is characterised by actin depolymerization 
and loss of PI(4,5)P2.  SapM may accelerate actin depolymerization by hydrolysing 
PI(4,5)P2 to ensure Mtb uptake by the host. The early phagosome is characterised by 
the presence of Rab5, PI3P and EEA1, essential molecules to allow early phagosome-
endosome fusion. Hydrolysis of PI3P by SapM and MptpB prevents the Rab5-Rab7 
exchange that mediates the transition to late phagosome. Phagosomal acidification 
occurs by acquisition of V-ATPase that uses ATP. SapM may contribute in preventing 
acidification by hydrolysis of ATP. MptpA inhibits phagosome acidification by 
hydrolysis of VPS33B and inhibition of V-ATPase trafficking to the late phagosome. 
MptpB hydrolyses PI(3,5)P2, which is required for late phagosome/phagolysosome 
fusion. The coordinated action of the three secreted phosphatases prevents 
phagolysosome fusion and pathogen destruction thus promoting Mtb survival in the 
host. 
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